Works matching IS 15330028 AND DT 2021 AND VI 20 AND IP 4
Results: 14
Cutaneous Lymphangitic Carcinomatosis as the First Sign of Recurrent Malignancy in a Patient With a History of Rectal Adenocarcinorna.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 368, doi. 10.1016/j.clcc.2021.09.010
- By:
- Publication type:
- Article
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 364, doi. 10.1016/j.clcc.2021.09.002
- By:
- Publication type:
- Article
Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD Deficiency.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 359, doi. 10.1016/j.clcc.2021.09.004
- By:
- Publication type:
- Article
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 354, doi. 10.1016/j.clcc.2021.07.005
- By:
- Publication type:
- Article
Response to Pembrolizumab in Advanced Anal Squamous Cell Carcinoma With High TMB and PD-L1 and PD-L2 Amplification.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 350, doi. 10.1016/j.clcc.2021.05.008
- By:
- Publication type:
- Article
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 342, doi. 10.1016/j.clcc.2021.09.009
- By:
- Publication type:
- Article
Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO).
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 299, doi. 10.1016/j.clcc.2021.05.005
- By:
- Publication type:
- Article
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 326, doi. 10.1016/j.clcc.2021.07.006
- By:
- Publication type:
- Article
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 318, doi. 10.1016/j.clcc.2021.07.003
- By:
- Publication type:
- Article
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 314, doi. 10.1016/j.clcc.2021.07.001
- By:
- Publication type:
- Article
Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 305, doi. 10.1016/j.clcc.2021.05.007
- By:
- Publication type:
- Article
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 334, doi. 10.1016/j.clcc.2021.07.004
- By:
- Publication type:
- Article
The Evolving Field of Neoadjuvant Therapy in Locally-advanced Rectal Cancer: Evictence and Prospects.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 288, doi. 10.1016/j.clcc.2021.06.005
- By:
- Publication type:
- Article
Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 279, doi. 10.1016/j.clcc.2021.09.006
- By:
- Publication type:
- Article